Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jerry Vockley

Showing results (11-20 of 293) with videos related to

Pageof 30
Sort By:
Expert Review of Clinical Pharmacology|July 9, 2025
A pharmacological profile of triheptanoin for the treatment of long-chain fatty acid oxidation disordersRaelynn Forsyth, Jerry Vockley
Developmental Disabilities Research Reviews|June 26, 2013
Introduction: Neurodevelopmental issues in inborn errors of metabolismGeorgianne L Arnold, Jerry Vockley
The Journal of Pediatrics|September 23, 2020
Mitochondrial Disease and Coenzyme Q10 Deficiency: CommentaryAudrey C Woerner, Jerry Vockley
Science Translational Medicine|May 25, 2022
Lysine acylation causes collateral damage in inborn errors of metabolismEric S Goetzman, Jerry Vockley
Molecular Genetics and Metabolism|August 3, 2011
Thoroughly modern medicineGeorgianne L Arnold, Jerry Vockley
Cell Metabolism|June 2, 2026
Is an emerging pharmacotherapeutic era for rare mitochondrial diseases here?Jirair K Bedoyan, Jerry Vockley
Drugs|March 14, 2019
Phenylketonuria: Current Treatments and Future DevelopmentsUta Lichter-Konecki, Jerry Vockley
Pediatric Clinics of North America|March 6, 2018
Inborn Errors of Metabolism with Myopathy: Defects of Fatty Acid Oxidation and the Carnitine Shuttle SystemAreeg El-Gharbawy, Jerry Vockley
Clinical Therapeutics|August 4, 2022
Survey of Health Care Provider Understanding of Gene Therapy Research for Inherited Metabolic DisordersJoyanna Hansen, Radha Ramachandran, Jerry Vockley
Biochimie|December 3, 2014
Kinetic and spectral properties of isovaleryl-CoA dehydrogenase and interaction with ligandsAl-Walid A Mohsen, Jerry Vockley
Pageof 30

Showing results (11-20 of 293) with videos related to

Sort By:
Pageof 30
Expert Review of Clinical Pharmacology|July 9, 2025
A pharmacological profile of triheptanoin for the treatment of long-chain fatty acid oxidation disordersRaelynn Forsyth, Jerry Vockley
Developmental Disabilities Research Reviews|June 26, 2013
Introduction: Neurodevelopmental issues in inborn errors of metabolismGeorgianne L Arnold, Jerry Vockley
The Journal of Pediatrics|September 23, 2020
Mitochondrial Disease and Coenzyme Q10 Deficiency: CommentaryAudrey C Woerner, Jerry Vockley
Science Translational Medicine|May 25, 2022
Lysine acylation causes collateral damage in inborn errors of metabolismEric S Goetzman, Jerry Vockley
Molecular Genetics and Metabolism|August 3, 2011
Thoroughly modern medicineGeorgianne L Arnold, Jerry Vockley
Cell Metabolism|June 2, 2026
Is an emerging pharmacotherapeutic era for rare mitochondrial diseases here?Jirair K Bedoyan, Jerry Vockley
Drugs|March 14, 2019
Phenylketonuria: Current Treatments and Future DevelopmentsUta Lichter-Konecki, Jerry Vockley
Pediatric Clinics of North America|March 6, 2018
Inborn Errors of Metabolism with Myopathy: Defects of Fatty Acid Oxidation and the Carnitine Shuttle SystemAreeg El-Gharbawy, Jerry Vockley
Clinical Therapeutics|August 4, 2022
Survey of Health Care Provider Understanding of Gene Therapy Research for Inherited Metabolic DisordersJoyanna Hansen, Radha Ramachandran, Jerry Vockley
Biochimie|December 3, 2014
Kinetic and spectral properties of isovaleryl-CoA dehydrogenase and interaction with ligandsAl-Walid A Mohsen, Jerry Vockley
Pageof 30